$ABUS I am heading into Monday with great optimism. In my opinion, the upside potential far outweighs the small near-term downside risk. The smart move for Moderna is to buy ABUS stock and end this patent dispute once and for all. The longer it goes on, the worse it is for Moderna and its insiders who have dumped Moderna stock at every opportunity. Moderna insiders have sold more than $200 million in Moderna stock since January. Moderna insiders could have bought all of ABUS stock before the ruling. The bottom line is that the stakes for Moderna are too high – in the tens of billions of dollars to hundreds of billions of dollars potentially. Even if it costs Moderna $1 billion to buy ABUS stock, it will be worth it. These are only my opinions, best wishes to longs.